Overcoming Drug Resistance and Treating Advanced Prostate Cancer

Most of the prostate cancers (PCa) in advanced stage will progress to castration-resistant prostate cancer (CRPC). Within CRPC group, 50-70% of the patients will develop bone metastasis in axial and other regions of the skeleton. Once PCa cells spread to the bone, currently, no treatment regimens ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Semenas, Julius, Allegrucci, Cinzia, Boorjian, Stephen A, Mongan, Nigel P, Persson, Jenny Liao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474961/
https://www.ncbi.nlm.nih.gov/pubmed/22746994
http://dx.doi.org/10.2174/138945012802429615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474961/
https://www.ncbi.nlm.nih.gov/pubmed/22746994
http://dx.doi.org/10.2174/138945012802429615

Ejemplares similares